Johnson & Johnson's $6.5 billion settlement proposal -- to be ... In 2016, J&J was were ordered to pay $55 million to a 62-year-old South Dakota woman who said she developed ovarian cancer after ...
Johnson & Johnson on Wednesday proposed a plan to pay nearly $6.5 billion to resolve tens of thousands of lawsuits claiming that its cosmetic talc-based powder causes cancer. Through a bankruptcy ...
AFP Contributor / Contributor / Getty Images Johnson & Johnson on Wednesday proposed a settlement that would pay roughly $6.5 billion to settle lawsuits alleging the company's talc powder caused ...
Johnson and Johnson reiterated in its statement on Wednesday, May 1, that “none of the talc-related claims against it have merit” getty Stock image of baby powder Johnson & Johnson has offered ...
J&J will buy Momenta Pharmaceuticals for roughly $6.5 billion in cash, paving the way for its Janssen unit to expand its efforts into autoimmune disease treatments. J&J will pay $52.50 for each ...
Five plaintiffs sued Johnson & Johnson on Wednesday, accusing the company of fraud through its use of a shell company's ...
Wednesday, Johnson & Johnson (NYSE:JNJ) announced its intention to proceed with a $6.475 billion settlement to resolve numerous lawsuits related to ... The pharmaceutical giant is set to pay ...
Pharmaceutical giant Johnson & Johnson is set to pay $6.475 billion to settle lawsuits alleging its talc-based products, often associated with health concerns, caused cancer. This unprecedented ...
that “none of the talc-related claims against it have merit” getty Stock image of baby powder Johnson & Johnson has offered to pay $6.475 billion in response to thousands of lawsuits that have alleged ...
Also Read: Johnson & Johnson Wants To Deal With Talc Lawsuit Overhang, Proposes $6.5B Settlement Package. At the data cutoff of March 22, 2024, 64 patients had been treated with TAR-210 ...
"The addition of Abiomed is an important step in our vision for the new Johnson & Johnson focused on Pharmaceutical and MedTech," said CEO Joaquin Duato. Johnson & Johnson said it will pay $380 ...
The fact that multiple Johnson & Johnson (NYSE:JNJ) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When analyzing insider ...